Exploring the Mechanism of Action of sanqi Flower in the Treatment of Depression and Its Clinical Observation Study Based on Network Pharmacology and Molecular Docking Technology

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400083018

Enrollment

Unknown

Registered

2024-04-15

Start date

2024-04-15

Completion date

Unknown

Last updated

2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Intervention group: Sanqi (Panax notoginseng) flower tea

Control group :Administered paroxetine

Eligibility

Sex/Gender

All

Age

25 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1.Male and female patients between the ages of 25-30, aiming to ensure that there are no psychological issues caused by the deterioration of other bodily functions. 2.The hospital psychiatrist diagnosed it as severe depression. 3.Has not received any other specific treatment.

Exclusion criteria

Exclusion criteria: (1) Patients with serious heart, liver, kidney, or other systemic diseases. (2) Pregnant or breastfeeding women. (3) Patients allergic to the study drug or materials

Design outcomes

Primary

Measure	Time frame
Mental Health Scale Score;	—

Countries

CHINA

Contacts

Public ContactLin Shaochen

Yunnan Provincial Psychiatric Hospital

3201809377@qq.com+86 178 6521 6918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026